Four Novel Gene Polymorphisms Cause Nuclear Age Related Cataract in Chinese People

Total Page:16

File Type:pdf, Size:1020Kb

Four Novel Gene Polymorphisms Cause Nuclear Age Related Cataract in Chinese People Four Novel Gene Polymorphisms Cause Nuclear Age Related Cataract in Chinese People Lin Wang First Aliated Hospital of Harbin Medical University Wencheng Zhao First Aliated Hospital of Harbin Medical University Yongbin Yu First Aliated Hospital of Harbin Medical University ping liu ( [email protected] ) Eye Hospital, The First Affiliated Hospital of Harbin Medical University, Harbin, P.R. China Research article Keywords: nuclear age-related cataract (NARC), single nucleotide polymorphism (SNP), protein structure Posted Date: February 13th, 2021 DOI: https://doi.org/10.21203/rs.3.rs-219650/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/24 Abstract Background More information on genetic variation can be obtained by exon sequencing for the diagnosis of nuclear age-related cataract (NARC). Methods In our present study, genomes of 12 DNA samples were sequenced. The average effective depth was 10× when using Illumina sequencing. After conducting whole-exon sequencing, we further performed depth analysis and spectrum analysis to determine the gene polymorphism sites closely associated with NARC. Results In genes showing single nucleotide polymorphism (SNP), there were 18,699 synonymous mutations and 17,975 missense mutations in the coding region. A total of 4,944 insertions and deletions (indels) were found. Among them, 1329 indels exhibited polymorphism and were further analyzed. Whole-exon sequencing previously showed polymorphism associated with ARC and known pathways associated with protein synthesis and metabolism. Following depth analysis (GO and KEGG analysis), we identied 20 promising candidate genes that were closely related to NARC. We further performed spectrum analysis for 26 polymorphism sites and found that ZNF573 (rs3095726, SNP), ZNF862 (rs62621204, SNP), SYNE3 (rs76499929, indel), and GAS2L2 (rs78557458, SNP) had statistically signicant relationship with NARC. The 3D protein structure showed obvious changes for ZNF573 (rs3095726, SNP) and GAS2L2 (rs78557458, SNP). Conclusions Our ndings provide the basis for further studies and discovery of key genes associated with NARC. Key Messages 1 For studying the pathogenesis of nuclear age-related cataract 2 We found that ZNF573 (rs3095726, SNP), ZNF862 (rs62621204, SNP), SYNE3 (rs76499929, indel), and GAS2L2 (rs78557458, SNP) had statistically signicant relationship with NARC 3 Our ndings provide the basis for further studies and discovery of key genes associated with NARC. Background Age-related cataracts (ARCs) are characterized by visual impairment and lens opacities, and they are the major reason of blindness worldwide [1]. Both genetic variations and environmental factors can lead to ARCs [2]. Various interaction factors have been conrmed to be involved in the complex cataract formation process. Both genetic and environmental factors have been conrmed to be involved in the pathogenesis of ARC [3]. Genetic polymorphism is considered to be an integral part of genetic risk for developing ARC. Many researchers have studied the relationship between genetic polymorphism and ARC sensitivity [4,5]. Alterations in the molecular architecture of lens proteins lead to the development of cataract [1]. The annual worldwide incidence of cataract has been estimated to be 17.7 million [2]. To date, there is no effective pharmacological treatment for cataract because it is an irreversible age-related process [3]. ARCs are classied into cortical cataract, nuclear cataract, and posterior subcapsular cataract (PSC). In cortical cataract, the cytoplasm of mature ber cells are damaged in the outer third of the lens. An increase in light scattering is a characteristic of nuclear cataract with yellow or brown coloration [4]. Furthermore, less than 10% of ARC cases are PSC [5]. We assessed the cataract status of participants and examined their eye structure with slit lamp (Streit BQ-900, Hague; Haag Streit AG, Köniz, Switzerland) [6]. We used the standard lens opacication classication system III (LOCS III) to classify cataract types. On the basis of the standard criterion, we divided the type of cataracts into cortical cataracts (LOCS III score ≥2), nuclear cataracts ((LOCS III score ≥4), or mixed type. In the present study, we analyzed blood samples of patients with nuclear cataract. It is generally believed that genetic factors play an important role in the formation of ARC; however, the exact cause of ARC remains unclear [7]. The etiology of ARC is multifactorial, and both genetic variations and environmental factors are associated with the disease. Genetic factors are closely related to the pathogenesis of ARCs. In twin studies, the heritability of nuclear subtypes was found to be 48% [8] . Genetic variations may increase the sensitivity of lens to environmental risk factors and may be directly involved in the formation of ARC [9] . Through the target enrichment strategy, whole-exome sequencing (WES) is a high-throughput genomic technology that selectively captures the coding region of the genome [10-12]. WES uses oligonucleotide probes that perform selective hybridization [10,12,13], and targeting enrichment is achieved by capturing the entire coding region of the genome. Because exons constitute approximately 2% of the genome [14] , WES technology provides high coverage at low cost [14] with faster speed. After the rst successful application in the discovery of candidate genes for Miller’s syndrome [15], WES has been adopted for investigating a number of complex disorders and Mendelian [16-17]. Page 2/24 WES was used in the NHLBI GO Exome Sequencing Project, Exome Aggregation Consortium (EXAC), and other 1,000 genome projects to identify rare disease- related variants and to classify the variations in the population [18–22]. Since 2011, WES has also been frequently used as a diagnostic tool in clinical genetics laboratories [23–25]. WES is a useful clinical diagnostic tool to identify disease-related variants in patients [26–27]. Currently, to determine whether disease-related mutations in patients are related to mutations in coding regions, researchers are focusing on sequencing exons rather than entire genomes. Recently, several studies have identied variants strongly associated with disease phenotypes [26–27] by successful application of WES technology. Because of the uneven coverage of different WES datasets along the exon length under high-resolution detection, in the variation calling analysis, the impact identication of new variations that may be of clinical signicance. In the present study, we analyzed and determined the key issues related to sequence structure, which lead to low coverage, and systematically studied the different parameters that may affect WES. To date, WES has become a major genetic tool, with over 100,000 exons sequenced in several diagnostic centers [28] . To ll the gap and identify the mutation accurately, it is very important to improve the mapping algorithm and modify the design of target sequence capture technology and estimation of genetic disease heritability. Large numbers of insertions and deletions (indels) and single-nucleotide polymorphisms (SNPs) have been identied using the next-generation sequencing (NGS) technology. In many species and human diseases, short indels are involved in phenotypic diversity and are regarded as the second most common form of genomic variation [29]. It is feasible to identify and study the molecular basis of SNPs and indels for ARC. However, to date, very limited investigations have been reported using the method of whole-genome resequencing for genes related to ARC. The present study aimed to detect polymorphic SNP sites and indels including short indels [1–49 base pairs (bp)] across the whole exon sequence in 8 patients with NARC. In patients with NARC, it is important to identify the differences in SNPs and indels, which result in functional genes. Methods Subjects A total of eight subjects were recruited from the Eye Hospital of Harbin Medical University. All the subjects received comprehensive ophthalmic examinations, including vision, slit lamp microscopy, and ophthalmoscopy. None of the subjects had blood relations (at least not among the four grandparents). All the subjects claimed to be Han (all four grandparents were Han). The study was approved by the institutional review committee, following the principles of the Helsinki declaration, and informed consent was signed by all subjects. Lens opacity grading According to LOCS III, a trained ophthalmologist graded the lens opacity of each right eye as cortical (C), nuclear color (NC), nuclear opalescence (NO), posterior subcapsular (P), or mixed type after pupil dilation with 1% tropicamide. Nuclear ARC group and control group All subjects with NARC were included in this study, and the case and control groups were recruited according to the grading conditions. The following exclusion criteria were used: (1) history of diseases such as tumor, cancer, respiratory disease, kidney disease, or history of diabetes; (2) pseudophakia or aphakia in both eyes; (3) ocular surgery history in either eye; (4) complications with other eye diseases such as fundus diseases, dislocated lens, glaucoma, trauma, high myopia, and uveitis; and (5) under 45 years of age. Blood sample collection and DNA isolation Peripheral blood (12 ml) samples of all subjects (8 disease cases and 4 controls) were collected in EDTA tubes and stored at -80°C before use. DNA was extracted from whole blood cells by using the mammalian
Recommended publications
  • Binding Specificities of Human RNA Binding Proteins Towards Structured
    bioRxiv preprint doi: https://doi.org/10.1101/317909; this version posted March 1, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Binding specificities of human RNA binding proteins towards structured and linear 2 RNA sequences 3 4 Arttu Jolma1,#, Jilin Zhang1,#, Estefania Mondragón4,#, Teemu Kivioja2, Yimeng Yin1, 5 Fangjie Zhu1, Quaid Morris5,6,7,8, Timothy R. Hughes5,6, Louis James Maher III4 and Jussi 6 Taipale1,2,3,* 7 8 9 AUTHOR AFFILIATIONS 10 11 1Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Solna, Sweden 12 2Genome-Scale Biology Program, University of Helsinki, Helsinki, Finland 13 3Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom 14 4Department of Biochemistry and Molecular Biology and Mayo Clinic Graduate School of 15 Biomedical Sciences, Mayo Clinic College of Medicine and Science, Rochester, USA 16 5Department of Molecular Genetics, University of Toronto, Toronto, Canada 17 6Donnelly Centre, University of Toronto, Toronto, Canada 18 7Edward S Rogers Sr Department of Electrical and Computer Engineering, University of 19 Toronto, Toronto, Canada 20 8Department of Computer Science, University of Toronto, Toronto, Canada 21 #Authors contributed equally 22 *Correspondence: [email protected] 23 24 25 SUMMARY 26 27 Sequence specific RNA-binding proteins (RBPs) control many important 28 processes affecting gene expression. They regulate RNA metabolism at multiple 29 levels, by affecting splicing of nascent transcripts, RNA folding, base modification, 30 transport, localization, translation and stability. Despite their central role in most 31 aspects of RNA metabolism and function, most RBP binding specificities remain 32 unknown or incompletely defined.
    [Show full text]
  • Whole Exome Sequencing in Families at High Risk for Hodgkin Lymphoma: Identification of a Predisposing Mutation in the KDR Gene
    Hodgkin Lymphoma SUPPLEMENTARY APPENDIX Whole exome sequencing in families at high risk for Hodgkin lymphoma: identification of a predisposing mutation in the KDR gene Melissa Rotunno, 1 Mary L. McMaster, 1 Joseph Boland, 2 Sara Bass, 2 Xijun Zhang, 2 Laurie Burdett, 2 Belynda Hicks, 2 Sarangan Ravichandran, 3 Brian T. Luke, 3 Meredith Yeager, 2 Laura Fontaine, 4 Paula L. Hyland, 1 Alisa M. Goldstein, 1 NCI DCEG Cancer Sequencing Working Group, NCI DCEG Cancer Genomics Research Laboratory, Stephen J. Chanock, 5 Neil E. Caporaso, 1 Margaret A. Tucker, 6 and Lynn R. Goldin 1 1Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD; 2Cancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD; 3Ad - vanced Biomedical Computing Center, Leidos Biomedical Research Inc.; Frederick National Laboratory for Cancer Research, Frederick, MD; 4Westat, Inc., Rockville MD; 5Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD; and 6Human Genetics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA ©2016 Ferrata Storti Foundation. This is an open-access paper. doi:10.3324/haematol.2015.135475 Received: August 19, 2015. Accepted: January 7, 2016. Pre-published: June 13, 2016. Correspondence: [email protected] Supplemental Author Information: NCI DCEG Cancer Sequencing Working Group: Mark H. Greene, Allan Hildesheim, Nan Hu, Maria Theresa Landi, Jennifer Loud, Phuong Mai, Lisa Mirabello, Lindsay Morton, Dilys Parry, Anand Pathak, Douglas R. Stewart, Philip R. Taylor, Geoffrey S. Tobias, Xiaohong R. Yang, Guoqin Yu NCI DCEG Cancer Genomics Research Laboratory: Salma Chowdhury, Michael Cullen, Casey Dagnall, Herbert Higson, Amy A.
    [Show full text]
  • The Genetics of Bipolar Disorder
    Molecular Psychiatry (2008) 13, 742–771 & 2008 Nature Publishing Group All rights reserved 1359-4184/08 $30.00 www.nature.com/mp FEATURE REVIEW The genetics of bipolar disorder: genome ‘hot regions,’ genes, new potential candidates and future directions A Serretti and L Mandelli Institute of Psychiatry, University of Bologna, Bologna, Italy Bipolar disorder (BP) is a complex disorder caused by a number of liability genes interacting with the environment. In recent years, a large number of linkage and association studies have been conducted producing an extremely large number of findings often not replicated or partially replicated. Further, results from linkage and association studies are not always easily comparable. Unfortunately, at present a comprehensive coverage of available evidence is still lacking. In the present paper, we summarized results obtained from both linkage and association studies in BP. Further, we indicated new potential interesting genes, located in genome ‘hot regions’ for BP and being expressed in the brain. We reviewed published studies on the subject till December 2007. We precisely localized regions where positive linkage has been found, by the NCBI Map viewer (http://www.ncbi.nlm.nih.gov/mapview/); further, we identified genes located in interesting areas and expressed in the brain, by the Entrez gene, Unigene databases (http://www.ncbi.nlm.nih.gov/entrez/) and Human Protein Reference Database (http://www.hprd.org); these genes could be of interest in future investigations. The review of association studies gave interesting results, as a number of genes seem to be definitively involved in BP, such as SLC6A4, TPH2, DRD4, SLC6A3, DAOA, DTNBP1, NRG1, DISC1 and BDNF.
    [Show full text]
  • Identification and Validation of a Gene Expression Signature That Predicts Outcome in Malignant Glioma Patients
    INTERNATIONAL JOURNAL OF ONCOLOGY 40: 721-730, 2012 Identification and validation of a gene expression signature that predicts outcome in malignant glioma patients ATSUSHI KAWAGUCHI4, NAOKI YAJIMA1, YOSHIHIRO KOMOHARA3, HIROSHI AOKI1, NAOTO TSUCHIYA1, JUMPEI HOMMA1, MASAKAZU SANO1, MANABU NATSUMEDA1, TAKEO UZUKA1, AKIHIKO SAITOH1, HIDEAKI TAKAHASHI1, YUKO SAKAI5, HITOSHI TAKAHASHI2, YUKIHIKO FUJII1, TATSUYUKI KAKUMA4 and RYUYA YAMANAKA5 Departments of 1Neurosurgery and 2Pathology, Brain Research Institute, Niigata University; 3Department of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University; 4Biostatistics Center, Kurume University; 5Graduate School for Health Care Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan Received August 16, 2011; Accepted October 3, 2011 DOI: 10.3892/ijo.2011.1240 Abstract. Better understanding of the underlying biology approaches, to reveal more clearly the biological features of of malignant gliomas is critical for the development of early glioblastoma, and to identify novel target molecules for diagnosis detection strategies and new therapeutics. This study aimed to and therapy of the disease. Several histological grading schemes define genes associated with survival. We investigated whether exist, and the World Health Organization (WHO) system is genes selected using random survival forests model could be currently the most widely used (3). A high WHO grade correlates used to define subgroups of gliomas objectively. RNAs from 50 with clinical progression and decreased survival. However, there non-treated gliomas were analyzed using the GeneChip Human are still many individual variations within diagnostic categories, Genome U133 Plus 2.0 Expression array. We identified 82 genes resulting in a need for additional prognostic markers. The inad- whose expression was strongly and consistently related to patient equacy of histopathological grading is evidenced, in part, by the survival.
    [Show full text]
  • Drosophila and Human Transcriptomic Data Mining Provides Evidence for Therapeutic
    Drosophila and human transcriptomic data mining provides evidence for therapeutic mechanism of pentylenetetrazole in Down syndrome Author Abhay Sharma Institute of Genomics and Integrative Biology Council of Scientific and Industrial Research Delhi University Campus, Mall Road Delhi 110007, India Tel: +91-11-27666156, Fax: +91-11-27662407 Email: [email protected] Nature Precedings : hdl:10101/npre.2010.4330.1 Posted 5 Apr 2010 Running head: Pentylenetetrazole mechanism in Down syndrome 1 Abstract Pentylenetetrazole (PTZ) has recently been found to ameliorate cognitive impairment in rodent models of Down syndrome (DS). The mechanism underlying PTZ’s therapeutic effect is however not clear. Microarray profiling has previously reported differential expression of genes in DS. No mammalian transcriptomic data on PTZ treatment however exists. Nevertheless, a Drosophila model inspired by rodent models of PTZ induced kindling plasticity has recently been described. Microarray profiling has shown PTZ’s downregulatory effect on gene expression in fly heads. In a comparative transcriptomics approach, I have analyzed the available microarray data in order to identify potential mechanism of PTZ action in DS. I find that transcriptomic correlates of chronic PTZ in Drosophila and DS counteract each other. A significant enrichment is observed between PTZ downregulated and DS upregulated genes, and a significant depletion between PTZ downregulated and DS dowwnregulated genes. Further, the common genes in PTZ Nature Precedings : hdl:10101/npre.2010.4330.1 Posted 5 Apr 2010 downregulated and DS upregulated sets show enrichment for MAP kinase pathway. My analysis suggests that downregulation of MAP kinase pathway may mediate therapeutic effect of PTZ in DS. Existing evidence implicating MAP kinase pathway in DS supports this observation.
    [Show full text]
  • Peripheral Neuropathy Linked Mrna Export Factor GANP Reshapes Gene
    bioRxiv preprint doi: https://doi.org/10.1101/2021.05.18.444636; this version posted May 18, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Peripheral neuropathy linked mRNA export factor GANP 2 reshapes gene regulation in human motor neurons 3 4 Rosa Woldegebriel1,2, Jouni Kvist1, Matthew White2, Matilda Sinkko1, Satu Hänninen3,4, 5 Markus T Sainio1, Rubén Torregrosa-Munumer1, Sandra Harjuhaahto1, Nadine Huber5, Sanna- 6 Kaisa Herukka6,7, Annakaisa Haapasalo5, Olli Carpen3,4, Andrew Bassett8, Emil Ylikallio1,9, 7 Jemeen Sreedharan2*, Henna Tyynismaa1,10,11* 8 9 1 Stem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, 10 00290 Helsinki, Finland. 11 2 Maurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology and 12 Neuroscience, King's College London, London, UK. 13 3 Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, 14 Finland. 15 4 Research Program in Systems Oncology, University of Helsinki, Helsinki, Finland. 16 5 A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, 17 Finland. 18 6 Department of Neurology, Kuopio University Hospital, Kuopio, Finland. 19 7 Neurology, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland. 20 8 Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK. 21 9 Clinical Neurosciences, Neurology, University of Helsinki and Helsinki University Hospital, 22 00290 Helsinki, Finland. 23 10 Department of Medical and Clinical Genetics, University of Helsinki, 00290 Helsinki, 24 Finland. 25 11 Neuroscience Center, Helsinki Institute of Life Science, University of Helsinki, Helsinki, 26 Finland.
    [Show full text]
  • The Human Nucleoporin Tpr Protects Cells from RNA-Mediated Replication Stress
    ARTICLE https://doi.org/10.1038/s41467-021-24224-3 OPEN The human nucleoporin Tpr protects cells from RNA-mediated replication stress Martin Kosar 1,2,9, Michele Giannattasio 1,3, Daniele Piccini 1, Apolinar Maya-Mendoza 4, Francisco García-Benítez5, Jirina Bartkova4,6, Sonia I. Barroso 5, Hélène Gaillard 5, Emanuele Martini 1, Umberto Restuccia1, Miguel Angel Ramirez-Otero 1, Massimiliano Garre1, Eleonora Verga1, Miguel Andújar-Sánchez 7, Scott Maynard 4, Zdenek Hodny2, Vincenzo Costanzo1,3, Amit Kumar 8, ✉ ✉ ✉ Angela Bachi 1, Andrés Aguilera 5 , Jiri Bartek 2,4,6 & Marco Foiani 1,3 1234567890():,; Although human nucleoporin Tpr is frequently deregulated in cancer, its roles are poorly understood. Here we show that Tpr depletion generates transcription-dependent replication stress, DNA breaks, and genomic instability. DNA fiber assays and electron microscopy visualization of replication intermediates show that Tpr deficient cells exhibit slow and asymmetric replication forks under replication stress. Tpr deficiency evokes enhanced levels of DNA-RNA hybrids. Additionally, complementary proteomic strategies identify a network of Tpr-interacting proteins mediating RNA processing, such as MATR3 and SUGP2, and functional experiments confirm that their depletion trigger cellular phenotypes shared with Tpr deficiency. Mechanistic studies reveal the interplay of Tpr with GANP, a component of the TREX-2 complex. The Tpr-GANP interaction is supported by their shared protein level alterations in a cohort of ovarian carcinomas. Our results reveal links between nucleoporins, DNA transcription and replication, and the existence of a network physically connecting replication forks with transcription, splicing, and mRNA export machinery. 1 IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milano, Italy.
    [Show full text]
  • Long Non-Coding RNA MCM3AP-AS1 Promotes Growth and Migration
    Yang et al. Molecular Medicine (2019) 25:55 Molecular Medicine https://doi.org/10.1186/s10020-019-0121-2 RESEARCH ARTICLE Open Access Long non-coding RNA MCM3AP-AS1 promotes growth and migration through modulating FOXK1 by sponging miR-138- 5p in pancreatic cancer Ming Yang1, Shijuan Sun2, Yao Guo1, Junjie Qin2 and Guangming Liu2* Abstract Background: Pancreatic cancer (PC) is a type of malignant gastrointestinal tumor. Long non-coding RNA MCM3AP antisense RNA 1 (MCM3AP-AS1) has been reported to stimulate proliferation, migration and invasion in several types of tumors. However, the role of MCM3AP-AS1 in PC remains unclear. Methods: MCM3AP-AS1, microRNA miR-138-5p (miR-138-5p) and FOXK1 levels were detected using quantitative real time PCR. Cell proliferation, migration and invasion were analyzed. Dual luciferase reporter assay was used to confirm the relationship between MCM3AP-AS1 and miR-138-5p, between miR-138-5p and FOXK1. Protein levels were identified using western blot analysis. Results: MCM3AP-AS1 overexpression promoted proliferation, migration and invasion in PC cells. MCM3AP-AS1 silencing showed a suppressive effect on cell growth in PC cells. Moreover, MCM3AP-AS1 knockdown suppressed tumor growth in mice. Dual luciferase reporter assay demonstrated MCM3AP-AS1 could sponge microRNA-138-5p (miR-138-5p), and FOXK1 could bind with miR-138-5p. Positive correlation between MCM3AP-AS1 and FOXK1 was testified, as well as negative correlation between miR-138-5p and FOXK1. MCM3AP-AS1 promoted FOXK1 expression by targeting miR-138-5p, and MCM3AP-AS1 facilitated growth and invasion in PC cells by FOXK1. Conclusion: MCM3AP-AS1 promoted growth and migration through modulating miR-138-5p/FOXK1 axis in PC, providing insights into MCM3AP-AS1/miR-138-5p/FOXK1 axis as novel candidates for PC therapy from bench to clinic.
    [Show full text]
  • Binding Specificities of Human RNA Binding Proteins Towards Structured and Linear RNA Sequences
    bioRxiv preprint doi: https://doi.org/10.1101/317909; this version posted May 16, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Binding specificities of human RNA binding proteins towards structured and linear 2 RNA sequences 3 4 Arttu Jolma1,#, Jilin Zhang1,#, Estefania Mondragón4,#, Teemu Kivioja2, Yimeng Yin1, 5 Fangjie Zhu1, Quaid Morris5,6,7,8, Timothy R. Hughes5,6, Louis James Maher III4 and Jussi 6 Taipale1,2,3,* 7 8 9 AUTHOR AFFILIATIONS 10 11 1Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Solna, Sweden 12 2Genome-Scale Biology Program, University of Helsinki, Helsinki, Finland 13 3Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom 14 4Department of Biochemistry and Molecular Biology and Mayo Clinic Graduate School of 15 Biomedical Sciences, Mayo Clinic College of Medicine and Science, Rochester, USA 16 5Department of Molecular Genetics, University of Toronto, Toronto, Canada 17 6Donnelly Centre, University of Toronto, Toronto, Canada 18 7Edward S Rogers Sr Department of Electrical and Computer Engineering, University of 19 Toronto, Toronto, Canada 20 8Department of Computer Science, University of Toronto, Toronto, Canada 21 22 #Authors contributed equally 23 *Correspondence: [email protected] 24 25 26 ABSTRACT 27 28 Sequence specific RNA-binding proteins (RBPs) control many important 29 processes affecting gene expression. They regulate RNA metabolism at multiple 30 levels, by affecting splicing of nascent transcripts, RNA folding, base modification, 31 transport, localization, translation and stability. Despite their central role in most 32 aspects of RNA metabolism and function, most RBP binding specificities remain 33 unknown or incompletely defined.
    [Show full text]
  • Downloaded from [22]
    BMC Genomics BioMed Central Research article Open Access Cell array-based intracellular localization screening reveals novel functional features of human chromosome 21 proteins Yu-Hui Hu1,2, Hans-Jörg Warnatz1, Dominique Vanhecke1, Florian Wagner3, Andrea Fiebitz1, Sabine Thamm1, Pascal Kahlem1,4, Hans Lehrach1, Marie- Laure Yaspo1 and Michal Janitz*1 Address: 1Department of Vertebrate Genomics, Max Planck Institute for Molecular Genetics, 14195 Berlin, Germany, 2FU Berlin, Department of Biology, Chemistry and Pharmacy, 14195 Berlin, Germany, 3RZPD German Resource Center for Genome Research, 14059 Berlin, Germany and 4Department of Hematology, Oncology, and Tumor Immunology, Humboldt University, Charite, Berlin, Germany Email: Yu-Hui Hu - [email protected]; Hans-Jörg Warnatz - [email protected]; Dominique Vanhecke - [email protected]; Florian Wagner - [email protected]; Andrea Fiebitz - [email protected]; Sabine Thamm - [email protected]; Pascal Kahlem - [email protected]; Hans Lehrach - [email protected]; Marie- Laure Yaspo - [email protected]; Michal Janitz* - [email protected] * Corresponding author Published: 16 June 2006 Received: 13 March 2006 Accepted: 16 June 2006 BMC Genomics 2006, 7:155 doi:10.1186/1471-2164-7-155 This article is available from: http://www.biomedcentral.com/1471-2164/7/155 © 2006 Hu et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Background: Trisomy of human chromosome 21 (Chr21) results in Down's syndrome, a complex developmental and neurodegenerative disease.
    [Show full text]
  • A Yeast-Based Model for Hereditary Motor and Sensory Neuropathies: a Simple System for Complex, Heterogeneous Diseases
    International Journal of Molecular Sciences Review A Yeast-Based Model for Hereditary Motor and Sensory Neuropathies: A Simple System for Complex, Heterogeneous Diseases Weronika Rzepnikowska 1, Joanna Kaminska 2 , Dagmara Kabzi ´nska 1 , Katarzyna Bini˛eda 1 and Andrzej Kocha ´nski 1,* 1 Neuromuscular Unit, Mossakowski Medical Research Centre Polish Academy of Sciences, 02-106 Warsaw, Poland; [email protected] (W.R.); [email protected] (D.K.); [email protected] (K.B.) 2 Institute of Biochemistry and Biophysics Polish Academy of Sciences, 02-106 Warsaw, Poland; [email protected] * Correspondence: [email protected] Received: 19 May 2020; Accepted: 15 June 2020; Published: 16 June 2020 Abstract: Charcot–Marie–Tooth (CMT) disease encompasses a group of rare disorders that are characterized by similar clinical manifestations and a high genetic heterogeneity. Such excessive diversity presents many problems. Firstly, it makes a proper genetic diagnosis much more difficult and, even when using the most advanced tools, does not guarantee that the cause of the disease will be revealed. Secondly, the molecular mechanisms underlying the observed symptoms are extremely diverse and are probably different for most of the disease subtypes. Finally, there is no possibility of finding one efficient cure for all, or even the majority of CMT diseases. Every subtype of CMT needs an individual approach backed up by its own research field. Thus, it is little surprise that our knowledge of CMT disease as a whole is selective and therapeutic approaches are limited. There is an urgent need to develop new CMT models to fill the gaps.
    [Show full text]
  • Mrna Expression in Human Leiomyoma and Eker Rats As Measured by Microarray Analysis
    Table 3S: mRNA Expression in Human Leiomyoma and Eker Rats as Measured by Microarray Analysis Human_avg Rat_avg_ PENG_ Entrez. Human_ log2_ log2_ RAPAMYCIN Gene.Symbol Gene.ID Gene Description avg_tstat Human_FDR foldChange Rat_avg_tstat Rat_FDR foldChange _DN A1BG 1 alpha-1-B glycoprotein 4.982 9.52E-05 0.68 -0.8346 0.4639 -0.38 A1CF 29974 APOBEC1 complementation factor -0.08024 0.9541 -0.02 0.9141 0.421 0.10 A2BP1 54715 ataxin 2-binding protein 1 2.811 0.01093 0.65 0.07114 0.954 -0.01 A2LD1 87769 AIG2-like domain 1 -0.3033 0.8056 -0.09 -3.365 0.005704 -0.42 A2M 2 alpha-2-macroglobulin -0.8113 0.4691 -0.03 6.02 0 1.75 A4GALT 53947 alpha 1,4-galactosyltransferase 0.4383 0.7128 0.11 6.304 0 2.30 AACS 65985 acetoacetyl-CoA synthetase 0.3595 0.7664 0.03 3.534 0.00388 0.38 AADAC 13 arylacetamide deacetylase (esterase) 0.569 0.6216 0.16 0.005588 0.9968 0.00 AADAT 51166 aminoadipate aminotransferase -0.9577 0.3876 -0.11 0.8123 0.4752 0.24 AAK1 22848 AP2 associated kinase 1 -1.261 0.2505 -0.25 0.8232 0.4689 0.12 AAMP 14 angio-associated, migratory cell protein 0.873 0.4351 0.07 1.656 0.1476 0.06 AANAT 15 arylalkylamine N-acetyltransferase -0.3998 0.7394 -0.08 0.8486 0.456 0.18 AARS 16 alanyl-tRNA synthetase 5.517 0 0.34 8.616 0 0.69 AARS2 57505 alanyl-tRNA synthetase 2, mitochondrial (putative) 1.701 0.1158 0.35 0.5011 0.6622 0.07 AARSD1 80755 alanyl-tRNA synthetase domain containing 1 4.403 9.52E-05 0.52 1.279 0.2609 0.13 AASDH 132949 aminoadipate-semialdehyde dehydrogenase -0.8921 0.4247 -0.12 -2.564 0.02993 -0.32 AASDHPPT 60496 aminoadipate-semialdehyde
    [Show full text]